GeneDx, Inc. Sustainability Profile
GeneDx, Inc., a leading player in the genomic testing industry, is headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in providing comprehensive genetic testing services, particularly in rare and inherited diseases. With a focus on precision medicine, GeneDx offers a range of unique products, including whole exome sequencing and targeted gene panels, which are designed to deliver accurate and actionable insights for healthcare providers. The company has achieved significant milestones, including the expansion of its testing capabilities and partnerships with various healthcare institutions. GeneDx is recognised for its commitment to innovation and quality, positioning itself as a trusted resource for clinicians and patients alike. With a strong market presence, GeneDx continues to advance the field of genomics, making substantial contributions to personalised healthcare solutions.
DitchCarbon Score
How does GeneDx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GeneDx, Inc.'s score of 20 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GeneDx, Inc.'s reported carbon emissions
GeneDx, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of emissions figures. The company is a current subsidiary of GeneDx Holdings Corp., which may influence its climate commitments and reporting practices. While GeneDx has not set explicit reduction targets or made specific climate pledges, it is important to note that emissions data and climate initiatives may be cascaded from its parent organisation, GeneDx Holdings Corp. However, no specific details regarding emissions or reduction initiatives from this source have been provided. In the context of the broader industry, many companies are increasingly focusing on sustainability and carbon reduction strategies. GeneDx, as part of this trend, may align its future commitments with industry standards, such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP), although no specific initiatives have been reported at this time. As the company develops its climate strategy, stakeholders can expect potential future commitments to address carbon emissions and sustainability practices.
How Carbon Intensive is GeneDx, Inc.'s Industry?
How Carbon Intensive is GeneDx, Inc.'s Location?
GeneDx, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
GeneDx, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
